Park Ha Biological Reports $918K Net Loss, Cash Plummets to $628K; Massive Dilution Authorized
BYAH is trading near its 52-week low of $0.365 (6.8% above the low).
Summary
Park Ha Biological Technology reported a $918K net loss for the six months ended April 30, 2026, with cash collapsing to $628K. The company has authorized a massive increase in shares to 300 billion and completed a $1.74M offering at $1.50 per share — a stark contrast to the current $0.39 stock price.
Key Events · Earnings and Guidance · BYAH
-
Net Loss of $918K on $1.26M Revenue
The company reported a net loss of $918,282 for the six months ended April 30, 2026, a 95% improvement from the prior-year period's $19.84M loss, which was driven by a one-time $19.95M share-based compensation charge. Revenue was essentially flat at $1.26M.
-
Cash Collapses to $628K
Cash and cash equivalents fell from $3.79M to $628K in six months. Operating activities used $114K, while investing activities consumed $5.35M, primarily for short-term investments. The company raised $2.24M from share issuances to partially offset the burn.
-
Franchisee Loan Losses Surge
The allowance for expected credit losses on loans to franchisees increased to $534,173 from $232,876, reflecting a sharp rise in past-due loans. This signals significant distress in the franchise network, which is the company's primary revenue driver.
-
Massive Dilution Authorized
Subsequent to the period end, shareholders approved an increase in authorized shares to 300 billion, up from 3 billion. The board also received authority to effect reverse stock splits of up to 5,000-for-1, giving it broad power to manage the share price and issue vast amounts of new equity.
Analysis · BYAH · Industrial Applications And Services
Park Ha Biological Technology's interim results reveal a company burning cash at an alarming rate while simultaneously laying the groundwork for extreme dilution. The net loss of $918,282 is a 95% improvement from the prior year, but only because the prior period included a one-time $19.95M share-based compensation charge — the underlying business generated just $1.26M in revenue with a $963K operating loss. Cash has collapsed from $3.79M to $628K in six months, driven by $5.35M in investing outflows (mostly short-term investments) and an operating cash burn of $114K. The company raised $2.24M from share issuances during the period, and subsequent events show it raised another $1.74M in a registered direct offering at $1.50 per share — a price that is nearly 4x the current $0.39 stock price, suggesting the offering was priced before the stock's collapse. Most critically, shareholders have approved an increase in authorized shares to 300 billion, giving the board a blank check for massive future dilution. The allowance for credit losses on franchisee loans surged to $534K, signaling deep distress in the franchise network. This filing paints a picture of a micro-cap company in survival mode, burning cash, diluting shareholders, and preparing for even more dilution — all while the stock trades near its lows.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 42% of the 419 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BYAH was trading at $0.39 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.5M. The 52-week trading range was $0.37 to $45.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.